1. Home
  2. ABVC vs GITS Comparison

ABVC vs GITS Comparison

Compare ABVC & GITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVC
  • GITS
  • Stock Information
  • Founded
  • ABVC 2015
  • GITS 2018
  • Country
  • ABVC United States
  • GITS South Korea
  • Employees
  • ABVC N/A
  • GITS N/A
  • Industry
  • ABVC Biotechnology: Pharmaceutical Preparations
  • GITS
  • Sector
  • ABVC Health Care
  • GITS
  • Exchange
  • ABVC Nasdaq
  • GITS Nasdaq
  • Market Cap
  • ABVC 9.9M
  • GITS 11.6M
  • IPO Year
  • ABVC N/A
  • GITS N/A
  • Fundamental
  • Price
  • ABVC $0.70
  • GITS $2.38
  • Analyst Decision
  • ABVC
  • GITS
  • Analyst Count
  • ABVC 0
  • GITS 0
  • Target Price
  • ABVC N/A
  • GITS N/A
  • AVG Volume (30 Days)
  • ABVC 1.2M
  • GITS 279.7K
  • Earning Date
  • ABVC 03-12-2025
  • GITS 11-20-2024
  • Dividend Yield
  • ABVC N/A
  • GITS N/A
  • EPS Growth
  • ABVC N/A
  • GITS N/A
  • EPS
  • ABVC N/A
  • GITS N/A
  • Revenue
  • ABVC $509,788.00
  • GITS N/A
  • Revenue This Year
  • ABVC N/A
  • GITS N/A
  • Revenue Next Year
  • ABVC N/A
  • GITS N/A
  • P/E Ratio
  • ABVC N/A
  • GITS N/A
  • Revenue Growth
  • ABVC N/A
  • GITS 85.47
  • 52 Week Low
  • ABVC $0.40
  • GITS $0.10
  • 52 Week High
  • ABVC $1.73
  • GITS $5.06
  • Technical
  • Relative Strength Index (RSI)
  • ABVC 75.66
  • GITS N/A
  • Support Level
  • ABVC $0.40
  • GITS N/A
  • Resistance Level
  • ABVC $0.88
  • GITS N/A
  • Average True Range (ATR)
  • ABVC 0.08
  • GITS 0.00
  • MACD
  • ABVC 0.02
  • GITS 0.00
  • Stochastic Oscillator
  • ABVC 62.42
  • GITS 0.00

About ABVC ABVC BioPharma Inc.

ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.

About GITS Global Interactive Technologies Inc. Common Stock

Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.

Share on Social Networks: